INTT Quote, Financials, Valuation and Earnings

AXT has a net margin of 1.64% compared to inTest's net margin of -12.42%. inTest's return on equity of 2.9% beat AXT's return on equity of -3.81%.

inTest has a consensus price target of --, signalling upside risk potential of 49.74%. On the other hand AXT has an analysts' consensus of -- which suggests that it could grow by 138.53%. Given that AXT has higher upside potential than inTest, analysts believe AXT is more attractive than inTest.

inTest has a beta of 1.887, which suggesting that the stock is 88.712% more volatile than S&P 500. In comparison AXT has a beta of 2.150, suggesting its more volatile than the S&P 500 by 115.027%.

inTest has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AXT offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. inTest pays -- of its earnings as a dividend. AXT pays out -- of its earnings as a dividend.

inTest quarterly revenues are $30.3M, which are larger than AXT quarterly revenues of $23.6M. inTest's net income of $495K is higher than AXT's net income of -$2.9M. Notably, inTest's price-to-earnings ratio is 34.91x while AXT's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for inTest is 0.77x versus 0.99x for AXT. Usually stocks with elevated PS ratios are considered overvalued.

Entegris has a net margin of 1.64% compared to inTest's net margin of 9.61%. inTest's return on equity of 2.9% beat Entegris's return on equity of 6.6%.

inTest has a consensus price target of --, signalling upside risk potential of 49.74%. On the other hand Entegris has an analysts' consensus of -- which suggests that it could grow by 30.82%. Given that inTest has higher upside potential than Entegris, analysts believe inTest is more attractive than Entegris.

inTest has a beta of 1.887, which suggesting that the stock is 88.712% more volatile than S&P 500. In comparison Entegris has a beta of 1.235, suggesting its more volatile than the S&P 500 by 23.523%.

inTest has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Entegris offers a yield of 0.4% to investors and pays a quarterly dividend of $0.10 per share. inTest pays -- of its earnings as a dividend. Entegris pays out 33.33% of its earnings as a dividend. Entegris's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

inTest quarterly revenues are $30.3M, which are smaller than Entegris quarterly revenues of $807.7M. inTest's net income of $495K is lower than Entegris's net income of $77.6M. Notably, inTest's price-to-earnings ratio is 34.91x while Entegris's PE ratio is 65.87x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for inTest is 0.77x versus 4.71x for Entegris. Usually stocks with elevated PS ratios are considered overvalued.

FormFactor has a net margin of 1.64% compared to inTest's net margin of 9.01%. inTest's return on equity of 2.9% beat FormFactor's return on equity of 14.83%.

inTest has a consensus price target of --, signalling upside risk potential of 49.74%. On the other hand FormFactor has an analysts' consensus of $53.56 which suggests that it could grow by 24.9%. Given that inTest has higher upside potential than FormFactor, analysts believe inTest is more attractive than FormFactor.

inTest has a beta of 1.887, which suggesting that the stock is 88.712% more volatile than S&P 500. In comparison FormFactor has a beta of 1.116, suggesting its more volatile than the S&P 500 by 11.61%.

inTest has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. FormFactor offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. inTest pays -- of its earnings as a dividend. FormFactor pays out -- of its earnings as a dividend.

inTest quarterly revenues are $30.3M, which are smaller than FormFactor quarterly revenues of $207.9M. inTest's net income of $495K is lower than FormFactor's net income of $18.7M. Notably, inTest's price-to-earnings ratio is 34.91x while FormFactor's PE ratio is 24.64x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for inTest is 0.77x versus 4.54x for FormFactor. Usually stocks with elevated PS ratios are considered overvalued.

IPG Photonics has a net margin of 1.64% compared to inTest's net margin of -100.19%. inTest's return on equity of 2.9% beat IPG Photonics's return on equity of -6.43%.

inTest has a consensus price target of --, signalling upside risk potential of 49.74%. On the other hand IPG Photonics has an analysts' consensus of -- which suggests that it could grow by 15.69%. Given that inTest has higher upside potential than IPG Photonics, analysts believe inTest is more attractive than IPG Photonics.

inTest has a beta of 1.887, which suggesting that the stock is 88.712% more volatile than S&P 500. In comparison IPG Photonics has a beta of 0.957, suggesting its less volatile than the S&P 500 by 4.268%.

inTest has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IPG Photonics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. inTest pays -- of its earnings as a dividend. IPG Photonics pays out -- of its earnings as a dividend.

inTest quarterly revenues are $30.3M, which are smaller than IPG Photonics quarterly revenues of $233.1M. inTest's net income of $495K is higher than IPG Photonics's net income of -$233.6M. Notably, inTest's price-to-earnings ratio is 34.91x while IPG Photonics's PE ratio is 23.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for inTest is 0.77x versus 3.22x for IPG Photonics. Usually stocks with elevated PS ratios are considered overvalued.